Literature DB >> 17651790

MDMA-like behavioral effects of N-substituted piperazines in the mouse.

H L Yarosh1, E B Katz, A Coop, W E Fantegrossi.   

Abstract

Few studies have characterized the subjective effects of N-substituted piperazines, but these drugs show potential for abuse in humans, and have often been associated with MDMA ("ecstasy") in this regard. The aim of the present study was to test the capacity of N-substituted piperazines to induce a head twitch response, alter locomotor activity, and induce MDMA-like discriminative stimulus effects in mice. Various doses of l-benzylpiperazine (BZP), 1-(3-trifluoromethylphenyl) piperazine (TFMPP), 1-(3-methoxybenzyl) piperazine (m-MeO-BZP) or meta-chlorophenyl piperazine (m-CPP) were administered to mice to determine the effects on these behavioral endpoints. BZP, but not its meta-methoxyl analogue, increased locomotor activity in a dose-dependent manner; the phenylpiperazines and m-MeO-BZP only decreased locomotor activity. TFMPP was the only compound active in the head twitch assay, eliciting a moderate head twitch response which was comparable to that previously observed with the MDMA enantiomers. BZP, TFMPP and m-CPP fully substituted in S(+)-MDMA-trained animals, but did not elicit significant drug lever responding in mice trained to discriminate R(-)-MDMA. m-MeO-BZP partially substituted for both training drugs. The present results suggest that BZP has stimulant-like effects, and that TFMPP has hallucinogen-like effects. Their structural analogues, however, do not share these behavioral profiles. Further studies into the relationships between the N-substituted piperazines and MDMA are warranted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17651790      PMCID: PMC2082056          DOI: 10.1016/j.pbb.2007.06.007

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  30 in total

1.  Altered neuroendocrine and behavioral responses to m-chlorophenylpiperazine in 3,4-methylenedioxymethamphetamine (MDMA) users.

Authors:  U D McCann; V Eligulashvili; M Mertl; D L Murphy; G A Ricaurte
Journal:  Psychopharmacology (Berl)       Date:  1999-11       Impact factor: 4.530

2.  The subjective effects of MDMA and mCPP in moderate MDMA users.

Authors:  M E Tancer; C E Johanson
Journal:  Drug Alcohol Depend       Date:  2001-12-01       Impact factor: 4.492

3.  The meta-chlorophenylpiperazine challenge test in cocaine addicts: hormonal and psychological responses.

Authors:  L Buydens-Branchey; M Branchey; P Fergeson; J Hudson; C McKernin
Journal:  Biol Psychiatry       Date:  1997-06-01       Impact factor: 13.382

4.  Two distinct central serotonin receptors with different physiological functions.

Authors:  S J Peroutka; R M Lebovitz; S H Snyder
Journal:  Science       Date:  1981-05-15       Impact factor: 47.728

5.  Reinforcing and discriminative stimulus effects of 1-benzylpiperazine and trifluoromethylphenylpiperazine in rhesus monkeys.

Authors:  W E Fantegrossi; G Winger; J H Woods; W L Woolverton; A Coop
Journal:  Drug Alcohol Depend       Date:  2005-02-14       Impact factor: 4.492

Review 6.  Piperazine-like compounds: a new group of designer drugs-of-abuse on the European market.

Authors:  D de Boer; I J Bosman; E Hidvégi; C Manzoni; A A Benkö; L J dos Reys; R A Maes
Journal:  Forensic Sci Int       Date:  2001-09-15       Impact factor: 2.395

7.  N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').

Authors:  Michael H Baumann; Robert D Clark; Allison G Budzynski; John S Partilla; Bruce E Blough; Richard B Rothman
Journal:  Neuropsychopharmacology       Date:  2005-03       Impact factor: 7.853

8.  Serotonin synthesis inhibition reveals distinct mechanisms of action for MDMA and its enantiomers in the mouse.

Authors:  William E Fantegrossi; Christina L Kiessel; Richard De la Garza; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

9.  Hallucinogen-like actions of 2,5-dimethoxy-4-(n)-propylthiophenethylamine (2C-T-7) in mice and rats.

Authors:  William E Fantegrossi; Andrew W Harrington; Justin R Eckler; Sadia Arshad; Richard A Rabin; Jerrold C Winter; Andrew Coop; Kenner C Rice; James H Woods
Journal:  Psychopharmacology (Berl)       Date:  2005-10-12       Impact factor: 4.530

10.  A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine.

Authors:  S J CORNE; R W PICKERING; B T WARNER
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  10 in total

Review 1.  Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA).

Authors:  J R Docherty
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

2.  Effects of the hallucinogen 2,5-dimethoxy-4-iodophenethylamine (2C-I) and superpotent N-benzyl derivatives on the head twitch response.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Neuropharmacology       Date:  2013-09-04       Impact factor: 5.250

Review 3.  Effect of Hallucinogens on Unconditioned Behavior.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Curr Top Behav Neurosci       Date:  2018

4.  The adrenergic receptor antagonist carvedilol interacts with serotonin 2A receptors both in vitro and in vivo.

Authors:  Kevin Sean Murnane; Osman F Guner; J Phillip Bowen; Kalyn M Rambacher; Nader H Moniri; Tyler J Murphy; Cedrick Maceo Daphney; Aboagyewaah Oppong-Damoah; Kenner C Rice
Journal:  Pharmacol Biochem Behav       Date:  2019-04-15       Impact factor: 3.533

5.  Effects of histamine H(3) receptor activation on the behavioral-stimulant effects of methamphetamine and cocaine in mice and squirrel monkeys.

Authors:  Matthew L Banks; Daniel F Manvich; Rayna M Bauzo; Leonard L Howell
Journal:  Pharmacology       Date:  2009-01-15       Impact factor: 2.547

6.  Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and its enantiomers in mice: pharmacokinetic considerations.

Authors:  William E Fantegrossi; Naoki Murai; Brian O Mathúna; Nieves Pizarro; Rafael de la Torre
Journal:  J Pharmacol Exp Ther       Date:  2009-03-10       Impact factor: 4.030

7.  The new psychoactive substances 5-(2-aminopropyl)indole (5-IT) and 6-(2-aminopropyl)indole (6-IT) interact with monoamine transporters in brain tissue.

Authors:  Julie A Marusich; Kateland R Antonazzo; Bruce E Blough; Simon D Brandt; Pierce V Kavanagh; John S Partilla; Michael H Baumann
Journal:  Neuropharmacology       Date:  2015-09-08       Impact factor: 5.250

8.  Dissociative and sympathomimetic toxicity associated with recreational use of 1-(3-trifluoromethylphenyl) piperazine (TFMPP) and 1-benzylpiperzine (BZP).

Authors:  David M Wood; Jenny Button; Satnam Lidder; John Ramsey; David W Holt; Paul I Dargan
Journal:  J Med Toxicol       Date:  2008-12

9.  Discriminative stimulus effects of psychostimulants and hallucinogens in S(+)-3,4-methylenedioxymethamphetamine (MDMA) and R(-)-MDMA trained mice.

Authors:  K S Murnane; N Murai; L L Howell; W E Fantegrossi
Journal:  J Pharmacol Exp Ther       Date:  2009-08-14       Impact factor: 4.030

10.  Investigation of the effects of 'piperazine-containing party pills' and dexamphetamine on interhemispheric communication using electroencephalography.

Authors:  HeeSeung Lee; Grace Y Wang; Louise E Curley; Rob R Kydd; Ian J Kirk; Bruce R Russell
Journal:  Psychopharmacology (Berl)       Date:  2016-06-11       Impact factor: 4.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.